{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:34:20Z","timestamp":1794018860685,"version":"4.8.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010801","name":"Xunta de Galicia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023961","name":"CIBERINFEC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ijantimicag.2024.107150","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T12:40:34Z","timestamp":1710852034000},"page":"107150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Activity of cefiderocol and innovative \u03b2-lactam\/\u03b2-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double \u03b2-lactamases under high and low permeability conditions"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1636-6429","authenticated-orcid":false,"given":"Tania","family":"Blanco-Mart\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1681-969X","authenticated-orcid":false,"given":"Isaac","family":"Alonso-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8387-3784","authenticated-orcid":false,"given":"Luc\u00eda","family":"Gonz\u00e1lez-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6737-0239","authenticated-orcid":false,"given":"Michelle","family":"Outeda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Guijarro-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"L\u00f3pez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0745-8914","authenticated-orcid":false,"given":"Mar\u00eda","family":"P\u00e9rez-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Aracil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8950-4384","authenticated-orcid":false,"given":"Lorena","family":"L\u00f3pez-Cerero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Fraile-Ribot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4949-0779","authenticated-orcid":false,"given":"Juan Carlos","family":"V\u00e1zquez-Ucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6340-7815","authenticated-orcid":false,"given":"Alejandro","family":"Beceiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n","family":"Bou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Arca-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2024.107150_bib0001","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41564-019-0492-8","article-title":"Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread","volume":"4","author":"David","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0002","doi-asserted-by":"crossref","first-page":"e02534-16","DOI":"10.1128\/AAC.02534-16","article-title":"Mutations in blaKPC-3 that confer ceftazidime-avibactam resistance encode novel KPC-3 variants that function as extended-spectrum \u03b2-lactamases","volume":"61","author":"Haidar","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0003","doi-asserted-by":"crossref","first-page":"e01454","DOI":"10.1128\/AAC.01454-17","article-title":"In vitro antibacterial properties of cefiderocol, a novel siderophore cephalosporin, against gram-negative bacteria","volume":"62","author":"Ito","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0004","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/jac\/dkab043","article-title":"Activity of imipenem\/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales","volume":"76","author":"V\u00e1zquez-Ucha","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0005","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/14787210.2020.1756775","article-title":"Meropenem\/vaborbactam: a next generation \u03b2-lactam \u03b2-lactamase inhibitor combination","volume":"18","author":"Novelli","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0006","doi-asserted-by":"crossref","first-page":"e00877","DOI":"10.1128\/AAC.00877-21","article-title":"Contribution of PER-type and NDM-type \u03b2-Lactamases to cefiderocol resistance in Acinetobacter baumannii","volume":"65","author":"Poirel","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0007","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jgar.2022.12.009","article-title":"In vitro-obtained meropenem-vaborbactam resistance mechanisms among clinical Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates","volume":"32","author":"Findlay","year":"2023","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2022.11.011","article-title":"Deciphering variable resistance to novel carbapenem-based \u03b2-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime\/avibactam","volume":"29","author":"Di Pilato","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106738","article-title":"Activity of aztreonam in combination with novel \u03b2-lactamase inhibitors against metallo-\u03b2-lactamase-producing Enterobacterales from Spain","volume":"61","author":"V\u00e1zquez-Ucha","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0010","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01676-21","article-title":"Assessment of activity and resistance mechanisms to cefepime in combination with the novel \u03b2-lactamase inhibitors zidebactam, taniborbactam, and enmetazobactam against a multicenter collection of carbapenemase-producing Enterobacterales","volume":"66","author":"V\u00e1zquez-Ucha","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0011","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1093\/jac\/dkv166","article-title":"OP0595, a new diazabicyclooctane: mode of action as a serine \u03b2-lactamase inhibitor, antibiotic and \u03b2-lactam \u2018enhancer\u2019","volume":"70","author":"Morinaka","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0012","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1021\/acs.jmedchem.9b01976","article-title":"Discovery of cyclic boronic acid QPX7728, an ultrabroad-spectrum inhibitor of serine and metallo-\u03b2-lactamases","volume":"63","author":"Hecker","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0013","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. Thirtieth Edition: M100. 2020."},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0014","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1093\/jac\/dkz209","article-title":"Unravelling ceftazidime\/avibactam resistance of KPC-28, a KPC-2 variant lacking carbapenemase activity","volume":"74","author":"Oueslati","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0015","doi-asserted-by":"crossref","first-page":"e00574","DOI":"10.1128\/AAC.00574-21","article-title":"Evolutionary trajectories toward ceftazidime-avibactam resistance in Klebsiella pneumoniae clinical isolates","volume":"65","author":"Carattoli","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0016","doi-asserted-by":"crossref","first-page":"e00039","DOI":"10.1128\/aac.00039-22","article-title":"Impact of acquired broad-spectrum \u03b2-lactamases on susceptibility to cefiderocol and newly developed \u03b2-lactam\/\u03b2-lactamase inhibitor combinations in Escherichia coli and Pseudomonas aeruginosa","volume":"66","author":"Poirel","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0017","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/jac\/dkad061","article-title":"In vitro activity of cefepime\/zidebactam and cefepime\/taniborbactam against aztreonam\/avibactam-resistant NDM-like-producing Escherichia coli clinical isolates","volume":"78","author":"Le Terrier","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106776","article-title":"Activity of aztreonam\/avibactam against metallo-\u03b2-lactamase-producing Enterobacterales from the UK: impact of penicillin-binding protein-3 inserts and CMY-42 \u03b2-lactamase in Escherichia coli","volume":"61","author":"Livermore","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0019","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jama.2022.22873","article-title":"Cefepime\/enmetazobactam vs piperacillin\/tazobactam and complicated urinary tract infection or acute pyelonephritis: reply","volume":"329","author":"Kaye","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0020","doi-asserted-by":"crossref","first-page":"e00105","DOI":"10.1128\/AAC.00105-19","article-title":"Beyond piperacillin-tazobactam: cefepime and AAI101 as a potent \u03b2-lactam\u2212\u03b2-lactamase inhibitor combination","volume":"63","author":"Papp-Wallace","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0021","doi-asserted-by":"crossref","first-page":"e01963","DOI":"10.1128\/AAC.01963-19","article-title":"VNRX-5133 (taniborbactam), a broad-spectrum inhibitor of serine- and metallo-\u03b2-lactamases, restores activity of cefepime in Enterobacterales and Pseudomonas aeruginosa","volume":"64","author":"Hamrick","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0022","doi-asserted-by":"crossref","first-page":"e00128","DOI":"10.1128\/AAC.00128-19","article-title":"In vitro and in vivo activities of \u03b2-lactams in combination with the novel \u03b2-lactam enhancers zidebactam and WCK 5153 against multidrug-resistant metallo-\u03b2-lactamase-producing Klebsiella pneumoniae","volume":"63","author":"Moya","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0023","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1093\/jac\/dkab213","article-title":"In vitro evolution of cefepime\/zidebactam (WCK 5222) resistance in Pseudomonas aeruginosa: dynamics, mechanisms, fitness trade-off and impact on in vivo efficacy","volume":"76","author":"Barcel\u00f3","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0024","doi-asserted-by":"crossref","first-page":"e00191","DOI":"10.1128\/aac.00191-22","article-title":"Increased blaKPC copy number and OmpK35 and OmpK36 porins disruption mediated resistance to imipenem\/relebactam and meropenem\/vaborbactam in a KPC-producing Klebsiella pneumoniae clinical isolate","volume":"66","author":"Gaibani","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106935","article-title":"In vitro development of imipenem\/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification","volume":"62","author":"Gato","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0026","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3390\/antibiotics12060999","article-title":"Interplay between OXA-10 \u03b2-lactamase production and low outer-membrane permeability in carbapenem resistance in Enterobacterales","volume":"12","author":"Alonso-Garc\u00eda","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0027","first-page":"e00212","volume":"64","author":"Lomovskaya","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107150_bib0028","doi-asserted-by":"crossref","first-page":"e00552","DOI":"10.1128\/AAC.00552-20","article-title":"Impact of intrinsic resistance mechanisms on potency of QPX7728, a new ultrabroad-spectrum beta-lactamase inhibitor of serine and metallo-beta-lactamases in Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii","volume":"64","author":"Lomovskaya","year":"2020","journal-title":"Antimicrob Agents Chemother"}],"updated-by":[{"DOI":"10.1016\/j.ijantimicag.2024.107264","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000}}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924000682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924000682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T09:11:47Z","timestamp":1714295507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857924000682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0924857924000682"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107150","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity of cefiderocol and innovative \u03b2-lactam\/\u03b2-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double \u03b2-lactamases under high and low permeability conditions","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107150"}}